Mini Review

Issue 4 - 2024

The prescriptive paradox of allergen immunotherapy for respiratory allergic diseases

Authors

Elio Novembre , Simona barni , Francesca Mori

Key words: Allergy immunotherapy (AIT), Italian Drug Agency (IDA), European Medicines Agency (EMA), Primary Care Professional (PCP), Subcutaneous immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)
DOI: 10.53151/2531-3916/2024-638
Publication Date: 2025-01-22

Abstract

Allergy immunotherapy (AIT) is an effective, safe, and cost-efficient treatment for allergic rhinitis and asthma. Nevertheless, the prescription of AIT is paradoxically low and is progressively decreasing in Italy. Barriers exist, including the lack of guidelines for primary care physicians (PCPs) and specialists, insufficient agreed-upon pathways between specialists and PCPs, and complexities in the prescriptive process. It is necessary to rethink the approach to this issue through a collaborative and integrated effort among all players involved in improving accessibility and utilization of AIT for the treatment of allergic respiratory diseases

References

  1. Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy 2017;72:1597-1631. https://doi.org/10.1111/all.13201
  2. Alvaro-Lozano M, Akdis CA, Akdis M, et al. EAACI Allergen Immunotherapy User’s Guide. Pediatr Allergy Immunol 2020;31(Suppl 25):1-101. https://doi.org/10.1111/pai.13189
  3. Dhami S, Kakourou A, Asamoah F, et al. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy 2017;72:1825-1848. https://doi.org/10.1111/all.13208
  4. Jutel M, Agache I, Bonini S, et al. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol 2016;137:358-368. https://doi.org/10.1016/j.jaci.2015.12.1300
  5. Levy ML, Bacharier LB, Bateman E, et al. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. npj Prim Care Respir Med 2023;33:7. https://doi.org/10.1038/s41533-023-00330-1
  6. Bousquet J, Pfaar O, Togias A, et al. 2019 ARIA Care pathways for allergen immunotherapy. Allergy 2019;74:2087-2102. https://doi.org/10.1111/all.13805
  7. Cox LS, Murphey A, Hankin C. The Cost-Effectiveness of Allergen Immunotherapy Compared with Pharmacotherapy for Treatment of Allergic Rhinitis and Asthma. Immunol Allergy Clin North Am 2020;40:69-85. https://doi.org/10.1016/j.iac.2019.09.003
  8. Woehlk C, Von Bülow A, Ghanizada M, et al. Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study. Eur Respir J 2022;60:2200446. https://doi.org/10.1183/13993003.00446-2022
  9. Ryan D, Gerth van Wijk R, Angier E, et al. Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy. Allergy 2018;73:827-836. https://doi.org/10.1111/all.13264
  10. Bonertz A, Roberts GC, Hoefnagel M, et al. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: a global perspective on the regulation of allergen products. Allergy 2018;73:64-76. https://doi.org/10.1111/all.13266
  11. Cerimoniale G. Indagine epidemiologica sulla gestione delle patologie allergiche da parte del pediatra di famiglia. Il Medico Pediatra 2017;4-8.
  12. Potter PC, Warner JO, Pawankar R, et al. Recommendations for competency in allergy training for undergraduates qualifying as medical practitioners: a position paper of the World Allergy Organization. Curr Allergy Clin Immunol 2011;24:125-129.
  13. Zuberbier T, Bachert C, Bousquet PJ, et al. GA2 LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy 2010;65:1525-1530. https://doi.org/10.1111/j.1398-9995.2010.02474.x
  14. Roberts G, Pfaar O, Akdis CA, et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy 2018;73:765-798. https://doi.org/10.1111/all.13317
  15. Musarra A, Bilò MB, Canonica GW, et al. Consensus on allergen specific immunotherapy. Eur Ann Allergy Clin Immunol 2013;45 (Suppl 3):1-49.
  16. Payno G, Bernardini R, Terracciano L, et al. Immunoterapia con allergeni (AIT): Consensus della Società Italiana di Allergologia e Immunologia Pediatrica (SIAIP) per la pratica clinica in pediatria. Rivista di Immunologia e Allergologia Pediatrica 2015;(4 Suppl 4):1-19.
  17. www.allergicamente.it/allergie/respiratorie
  18. www.ripartiamo2021.org/sito/index.php/associazioni/32-allergamici
  19. www.aaiito.it/news/intergruppo-parlamentare-sulle-allergie-respiratorie/

Downloads

pdf
Authors

Elio Novembre - Allergy Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

Simona barni - Allergy Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

Francesca Mori - Allergy Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright

Copyright (c) 2025 Italian Journal of Pediatric Allergy and Immunology

How to Cite
Novembre, E., barni, S., & Mori, F. (2025). The prescriptive paradox of allergen immunotherapy for respiratory allergic diseases. Italian Journal of Pediatric Allergy and Immunology, 38(4). https://doi.org/10.53151/2531-3916/2024-638
  • Abstract viewed - 317 times
  • pdf downloaded - 70 times